Pharm2 Flashcards
how do we measure drug clearance in body
half life (covalent bonds can affect, prolong this)
what type of bonding occurs between the beta blocker-receptor
ionic bond
A wide therapeutic index would indicate what:
a safe range to treat with little risk of harm
Can the same drug have different TI
yes, for example ppl take more ibuprofen for inflammation vs. pain so narrows the therapeutic index
Up-regulation
antagonist causes “weak” signal so more receptors
down regulation
from an agonist drug causing “stronger” signal, reduces receptors
tachyphylaxis
very fast tolerance build to drugs
atropine would be an agonist or antagonist to the parasympathetic
antagonist because it is anticholinergic
define titrate and taper in relation to dosing drugs
titrate-“start low and go slow”
Taper-wean them off
both help prevent risk of tolerance
It is important to use hyperreactivity/hyporeactivity to a drug vs. hypersensitivity (allergic rxn)
adverse drug reactions
the most common adverse drug reaction
digestive disturbances (esp. oral) and hypersensitivity
Type I hypersensitivity
immediate, IgE antibodies involved. requires a 1st exposure penicillin, food can cause anaphylaxis
Type IV Hypersensitivity
T cell mediated diseases, delayed onset, can occur at 1st exposure
what are the weakest bonds
hydrophobic (such as fat soluble substances that group together to avoids water, they are reversible
Where would you see a greater change in affect when giving a drug?
at lower concentrations…. the higher dose may see receptors saturated